Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
Abstract
Interferon (IFN)-alpha is a cytokine of the innate immune response that is well known for inducing behavioral alterations and has been used to study effects of cytokines on the nervous system. Limited data, however, are available on the sites of action of IFN-alpha within the brain and their relationship with specific IFN-alpha-induced symptoms. Using a longitudinal design, whole-brain metabolic activity as assessed by fluorine-18-labeled fluorodeoxyglucose uptake and positron emission tomography was examined before and 4 weeks after IFN-alpha administration in patients with malignant melanoma. Changes in metabolic activity in relevant brain regions were then correlated with IFN-alpha-induced behavioral changes. IFN-alpha administration was associated with widespread bilateral increases in glucose metabolism in subcortical regions including the basal ganglia and cerebellum. Decreases in dorsal prefrontal cortex glucose metabolism were also observed. Prominent IFN-alpha-induced behavioral changes included lassitude, inability to feel, and fatigue. Correlational analyses revealed that self-reported fatigue (specifically as assessed by the 'energy' subscale of the Visual Analog Scale of Fatigue) was associated with increased glucose metabolism in the left nucleus accumbens and putamen. These data indicate that IFN-alpha as well as other cytokines of the innate immune response may target basal ganglia nuclei, thereby contributing to fatigue-related symptoms in medically ill patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IFNα administration was found to be associated with increased glucose metabolism in the basal ganglia and cerebellum, which are involved in motor activity and motivation”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Capuron et al., 2007
In the citing paper
“the observed NDI increase has been interpreted as representing the inflammatory process.”
From NODDI in clinical research (2020) · cites this paper as Capuron et al., 2007
In the citing paper
“In agreement with this, cancer patients treated with IFN-α display decreased glucose metabolism in the dorsal prefrontal cortex but increased glucose metabolism in the cerebellum and basal ganglia73.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [73]
In the citing paper
“IFN-α therapy led to reports of fatigue in a sample of patients with malignant melanoma that were positively correlated with increased glucose metabolism in the basal ganglia (the left putamen and left NAc) (Capuron et al., 2007).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2007
In the citing paper
“IFN-α therapy led to reports of fatigue in a sample of patients with malignant melanoma that were positively correlated with increased glucose metabolism in the basal ganglia (the left putamen and left NAc) (Capuron et al., 2007).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2007
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages
Cox, R. W. (1996) · Computers and Biomedical Research · doi:10.1006/cbmr.1996.0014 · Cited by 10,913
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527 · cited 1×
“Given the role of dopamine pathways in activating frontal cortex neurons (Alexander et al, 1986), altered basal ganglia and dopamine function may also contribute to the reduced metabolic activity observed in the frontal cortex following IFN-a administration.”
BackgroundForman, S. D., Cohen, J. D., Fitzgerald, M., Eddy, W. F., Mintun, M. A., & Noll, D. C. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330508 · Cited by 3,202 · cited 1×
“05 was reached by the combination of the single-voxel threshold of p¼ 0.0001 and a cluster size threshold of 78 voxels, as determined by a Monte Carlo simulation performed with the AFNI routine AlphaSim (Forman et al, 1995).”
MethodInfluentialCytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citationThe Mini-Mental State Examination
Folstein, M. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790060110016 · Cited by 1,936
Cited by
Items 101–200 of 229
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Johnston, J. N., Greenwald, M. S., Henter, I. D., Kraus, C., Mkrtchian, A., Clark, N. G., Park, L. T., Gold, P. W., Zarate, C. A., & Kadriu, B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103518 · Cited by 79
Mackay, M. C. (2015) · Immunologic Research · doi:10.1007/s12026-015-8716-3 · Cited by 78
Udina, M., Moreno-España, J., Navinés, R., Giménez, M. D., Langohr, K., Gratacòs, M., Capuron, L., de la Torre, R., Sola, R. L., & Martín‐Santos, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.007 · Cited by 69
“be caused by toxic effects of IFN-alpha on blood cell counts (Collantes and Younossi, 2005) as well as by cytokines targeting ganglia nuclei and altering the dopamine pathway, whereas depression may be mainly related to alterations in the serotoninergic neurotransmission (Capuron et al., 2007).”
Self-citationThe Neurobiology of Motivational Deficits in Depression—An Update on Candidate Pathomechanisms
Treadway, M. T. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_400 · Cited by 73
Witek Janusek, L., Tell, D., Albuquerque, K., & Mathews, H. L. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.05.014 · Cited by 62
Elomaa, A.-P., Niskanen, L., Herzig, K.-H., Viinamäki, H., Hintikka, J., Koivumaa-Honkanen, H., Honkalampi, K., Valkonen-Korhonen, M., Harvima, I. T., & Lehto, S. M. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-2 · Cited by 62
“Both their absence and overexpression affects central nervous system functions such as synaptic plasticity, neurogenesis, and neuromodulation in varying ways, including activity within basal ganglia and the frontal cortex [3-6].”
BackgroundCho, H. J., Kivimäki, M., Bower, J. E., & Irwin, M. R. (2013) · Psychological Medicine · doi:10.1017/s0033291712002437 · Cited by 59
“To date, basal ganglia hypermetabolism – hence altered dopaminergic activities – has been related to physical fatigue and anterior cingulate activation to mental fatigue during IFN-a therapy of patients with malignant melanoma (Capuron et al. 2005, 2007).”
BackgroundCancer-related fatigue in the elderly
Giacalone, A., Quitadamo, D., Zanet, E., Berretta, M., Spina, M., & Tirelli, U. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1897-1 · Cited by 72
Role of cytokines and reactive oxygen species in brain aging
MohanKumar, S. M. J., Murugan, A., Palaniyappan, A., & MohanKumar, P. S. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111855 · Cited by 64
Cho, H. J., Seeman, T. E., Bower, J. E., Kiefe, C. I., & Irwin, M. R. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.008 · Cited by 55
Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression
Ely, B. A., Nguyen, T. N. B., Tobe, R. H., Walker, A., & Gabbay, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.678709 · Cited by 60
“Several positron emission tomography (PET) studies in adults have demonstrated changes in striatal glucose metabolism subsequent to immunotherapy (235, 236).”
BackgroundAppetite Regulation of TLR4-Induced Inflammatory Signaling
Li, Y., Jiang, Q., & Wang, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.777997 · Cited by 63
Byrne, M. L., Whittle, S., & Allen, N. B. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000311 · Cited by 52
Arnett, S., & Clark, I. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.004 · Cited by 58
“An effect of inflammatory mediators on the basal ganglia and cerebral cortex consistent with the behavioural changes seen in sickness behaviour has been noted by several authors, providing a mechanistic link between the described cytokine mediated changes in cellular neurophysiology and sickness behaviour (Brydon et a…”
BackgroundMood and metabolism: Anhedonia as a clinical target in Type 2 diabetes
Carter, J., & Swardfager, W. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.002 · Cited by 62
“…can impact dopamine reward circuits; administration of interferon-α as a treatment for hepatitis C alters metabolism in the basal ganglia, and experimental low-dose endotoxin decreases ventral striatum activation in response to reward cues (Capuron et al., 2007; Eisenberger et al., 2010).”
Schaefer, M., & Mauss, S. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801020177 · Cited by 53
Felger, J. C., Haroon, E., Woolwine, B. J., Raison, C. L., & Miller, A. H. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.12.013 · Cited by 42
Self-citationInflaming the Brain: CRPS a Model Disease to Understand Neuroimmune Interactions in Chronic Pain
Linnman, C., Becerra, L. R., & Borsook, D. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9422-8 · Cited by 47
“…therapy is associated with widespread bilateral increases in glucose metabolism in subcortical regions including the basal ganglia and cerebellum, and decreases in dorsal prefrontal cortex (Capuron et al. 2007) and behavioral symptoms including lassitude, inability to feel, and fatigue.”
Piser, T. M. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.02.006 · Cited by 50
“In addition to effects on error processing by dorsal ACC, IFNa treatment has also been shown to alter metabolic activity in basal ganglia circuits (Capuron et al., 2007).”
BackgroundAnhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions
Freed, R. D., Mehra, L. M., Laor, D., Patel, M., Alonso, C. M., Kim‐Schulze, S., & Gabbay, V. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1482000 · Cited by 46
“Neuroimaging work, using PET and fMRI modalities, adds to this literature by documenting the specific effects of inflammatory processes within the dopaminergic reward circuitry (Capuron et al. 2007, 2012; Eisenberger et al. 2010; Juengling et al. 2000).”
MethodMastocytosis in adulthood and neuropsychiatric disorders
Georgin‐Lavialle, S., Gaillard, R., Moura, D. S., & Hermine, O. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.013 · Cited by 52
Kautz, M. M., Coe, C. L., McArthur, B. A., Mac Giollabhui, N., Ellman, L. M., Abramson, L. Y., & Alloy, L. B. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.02.029 · Cited by 41
“Upregulated inflammatory activity alters neural activity in several brain regions linked to depression, including anterior cingulate and insular cortex, and limbic circuitry (Brydon et al., 2008; Capuron et al., 2007; Capuron et al., 2012; Eisenberger et al., 2010; Harrison et al., 2009).”
BackgroundSalamone, J. D., Correa, M., Farrar, A. M., Nunes, E. J., & Collins, L. E. (2010) · Future Neurology · doi:10.2217/fnl.10.19 · Cited by 40
Can we vaccinate against depression?
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.018 · Cited by 45
Albrecht, K., Droll, H., Giesler, J. M., Nashan, D., Meiß, F., & Reuter, K. (2013) · Psycho-Oncology · doi:10.1002/pon.3238 · Cited by 42
Neuropsychological Features of Adult Mastocytosis
Moura, D. S., Georgin‐Lavialle, S., Gaillard, R., & Hermine, O. (2014) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2014.02.001 · Cited by 49
Smith, R. S., Alkozei, A., Killgore, W. D. S., & Lane, R. D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.09.011 · Cited by 42
“…accumbens, basal ganglia, and cerebellum) as well as levels of multiple neuromodulators, including dopamine, norepinephrine, and serotonin (Brydon et al., 2008; CamachoArroyo et al., 2009; Capuron et al., 2012, 2007, 2005; Eisenberger et al., 2010; Felger et al., 2016; Harrison et al., 2009).”
BackgroundCognitive dysfunction in SLE: An understudied clinical manifestation
Mizrachi, M., Anderson, E., Carroll, K. R., Tehrani, N., Volpe, B. T., & Diamond, B. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102911 · Cited by 43
Lasselin, J., Layé, S., Barreau, J.-B., Rivet, A., Dulucq, M.-J., Gin, H., & Capuron, L. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.01.016 · Cited by 49
Self-citationMyalgic Encephalomyelitis: Symptoms and Biomarkers
Jason, L. A., Zinn, M. L., & Zinn, M. A. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150928105725 · Cited by 45
Interferon-alpha-Induced changes in NODDI predispose to the development of fatigue
Dowell, N. G., Bouyagoub, S., Tibble, J., Voon, V., Cercignani, M., & Harrison, N. A. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.040 · Cited by 36
“For example, chronic IFN-a administration is associated with increases in striatal 18FDG uptake (Capuron et al., 2007), an post first IFN-a injection) in the striatum and insula regions of interest”
BackgroundResultInfluentialSalamone, J. D., Correa, M., Yohn, S. E., Yang, J.-H., Somerville, M., Rotolo, R. A., & Presby, R. E. (2017) · Motivation Science · doi:10.1037/mot0000070 · Cited by 39
Park, S.-M., Gaykema, R. P. A., & Goehler, L. E. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.05.001 · Cited by 36
Dopamine, effort, and decision making: Theoretical comment on Bardgett et al. (2009).
Salamone, J. D. (2009) · Behavioral Neuroscience · doi:10.1037/a0015381 · Cited by 31
“…include a disorders of behavioral activation in humans, and they represent fundamental aspects of depression and other psychiatric and neurological disorders (Capuron et al., 2007; Demyttenaere et al., 2005; Majer et al., 2008; Salamone et al., 2006, 2007; Stahl, 2002; Yurgelun-Todd et al., 2007).”
BackgroundPost-stroke neuronal circuits and mental illnesses.
Naghavi, F. S., Koffman, E. E., Lin, B., & Du, J. (2019) · Europe PMC (PubMed Central) · Cited by 39
Positive association between serum quinolinic acid and functional connectivity following concussion
Meier, T. B., España, L. Y., Nitta, M. E., Teague, T. K., Brett, B. L., Nelson, L. D., McCrea, M., & Savitz, J. B. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.11.011 · Cited by 30
Karrenbauer, B. D., Müller, C. P., Ho, Y., Spanagel, R., Huston, J. P., Schwarting, R. K. W., & Pawlak, C. R. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.011 · Cited by 30
“Capuron et al. (2007) partially supported these results: Cancerpatientswhoreceived IFN-α therapyalso had decreasedmetabolism in the prefrontal cortex and the basal ganglia.”
BackgroundResultKwon, S., Lee, B., Yeom, M., Sur, B., Kim, M., Kim, S.-T., Park, H., Lee, H., & Hahm, D. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.009 · Cited by 30
Neuroimaging evidence of brain abnormalities in mastocytosis
Boddaert, N., Salvador, A., Chandesris, M., Lemaître, H., Grévent, D., Gauthier, C., Naggara, O. N., Georgin‐Lavialle, S., Moura, D. S., Munsch, F., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.137 · Cited by 30
Goldsmith, D. R., Massa, N., Pearce, B. D., Wommack, E. C., Alrohaibani, A., Goel, N., Cuthbert, B. N., Fargotstein, M., Felger, J. C., Haroon, E., et al. (2020) · Schizophrenia · doi:10.1038/s41537-020-0098-4 · Cited by 31
Self-citationGreene, R. K., Walsh, E. C., Mosner, M. G., & Dichter, G. S. (2018) · Biological Psychology · doi:10.1016/j.biopsycho.2018.12.008 · Cited by 30
“…Studies Consistent with preclinical evidence, human fMRI studies investigating the impact of inflammation on the brain have also shown distinct effects on dopaminergic neural circuitry (Capuron et al., 2007; Capuron et al., 2012; Dowell et al., 2016; Eisenberger et al., 2010; Felger et al., 2013).”
BackgroundResultClinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals
Schifitto, G., Deng, L., Yeh, T., Evans, S. R., Ernst, T., Zhong, J., & Clifford, D. B. (2010) · Journal of NeuroVirology · doi:10.1007/s13365-010-0010-5 · Cited by 26
“Additional support for basal ganglia dysregulation in fatigue states comes from fatigue associated with interferon-alpha treatment (Capuron et al. 2007).”
Sergeeva, M. G., Rech, J., Schett, G. A., & Heß, A. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0783-2 · Cited by 28
“The cytokines alter the metabolism of neurotransmitters serotonin [27, 28], dopamine [28–31], glutamate [32, 33], which in turn leads to decreased production of the trophic or growth factors necessary for neurogenesis and neuroplasticity [6, 34, 35], or norepinephrine [5, 6].”
Neuroimaging in the Kleine-Levin Syndrome
Engström, M., Latini, F., & Landtblom, A. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0866-y · Cited by 30
Parent-Roberge, H., Fontvieille, A., Maréchal, R., Wagner, J. R., Fülöp, T., Pavic, M., & Riesco, É. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100016 · Cited by 27
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Mancini, M., Natoli, S., Gardoni, F., Luca, M. D., & Pisani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065618 · Cited by 28
“Intriguingly, IFN-α administration also causes an increase in glucose metabolism in the putamen [206,213].”
BackgroundLiu, Q., Ely, B. A., Simkovic, S. J., Tao, A., Wolchok, R. E., Alonso, C. M., & Gabbay, V. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100153 · Cited by 27
“Several positron emission tomography (PET) studies have demonstrated changes in glucose metabolismwithin the striatum subsequent to immunotherapy in adults (Capuron et al., 2007; Juengling et al., 2000).”
BackgroundUthayathas, S., Masilamoni, G. J., Shaffer, C. L., Schmidt, C. J., Menniti, F. S., & Papa, S. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.015 · Cited by 23
“…that MP-10 had a pharmacodynamic effect in brain tissue in the tested dose range, the effect of the compound on brain [18F] Fluorodeoxyglucose (FDG) uptake was determined by positron emission tomography (PET) imaging, using a previously described protocol (Capuron et al., 2007; Henry et al., 2010).”
MethodImmune System Contributions to the Pathophysiology of Depression
Miller, A. H., & Raison, C. L. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.1.foc36 · Cited by 33
Self-citationInflammation and Mood Disorders: Proinflammatory Cytokines and the Pathogenesis of Depression
Currier, M. B., & Nemeroff, C. B. (2010) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523011009030212 · Cited by 28
Self-citationInflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders
Haroon, E., & Miller, A. H. (2017) · Modern trends in psychiatry · doi:10.1159/000470805 · Cited by 22
Self-citationTetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in mice
Vancassel, S., Fanet, H., Castanon, N., de Oliveira, C. M., Cussotto, S., & Capuron, L. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.016 · Cited by 30
Self-citationDepressive disorders in HIV/AIDS:A clinically focused narrative review
Medeiros, G. C., Smith, F. A., Trivedi, M. H., & Beach, S. R. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000252 · Cited by 19
Shi, W., Misra, S., Li, M., Su, J. S., Chong, L. P., McCuske, M., Williams, J. P., Xu, W., Ghoraie, L. S., Sutherland, D. R., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa037 · Cited by 24
Sun, J. P., Tian, T., Wang, Y., Yan, W., Zhang, B., Wang, K., Yang, H., & Huang, M. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105076 · Cited by 17
Sick and Tired: Mood, Fatigue, and Inflammation in Cancer
Kruse, J. L., & Strouse, T. B. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0555-3 · Cited by 18
Lisboa, S. F. D. S., Issy, A. C., Biojone, C., Montezuma, K., Fattori, V., Del-Bel, E. A., Guimarães, F. S., Cunha, F. Q., Verri, W. A., Jr., & Joca, S. R. L. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.11.008 · Cited by 21
“Moreover, the use of interferon α (IFN-α) produce significant changes in brain metabolism as well as psychotic and depressive symptoms in humans (Capuron et al., 2007; Drozdz et al., 2007).”
Are proinflammatory cytokines involved in an increased risk for depression by unhealthy diets?
Ekmekçioğlu, C. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.11.015 · Cited by 19
Savitz, J. B., Ford, B. N., Yeh, H., Akeman, E., Cosgrove, K. T., Clausen, A. N., Martell, C. R., Kirlić, N., Santiago, J., Teague, T. K., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720004389 · Cited by 15
“…or lipopolysaccharide is associated with decreased striatal dopamine release, disrupted cortico-striatal functional connectivity, blunted striatal responsivity to reward, and symptoms of anhedonia (Capuron et al., 2007; Capuron et al., 2012; Eisenberger et al., 2010; Felger & Treadway, 2017).”
BackgroundHIV Infection and Related Mental Disorders
Nosik, M. N., Lavrov, V. F., & Свитич, О. А. (2021) · Brain Sciences · doi:10.3390/brainsci11020248 · Cited by 16
“These phenomena were shown to be expressed in the form of hypermetabolism in the early stages of HIV infection and hypometabolism in the later stages of the infectious process [60].”
BackgroundPanek, M., Pietras, T., Witusik, A., Wieteska, Ł., Małachowska, B., Mokros, Ł., Fendler, W. M., Szemraj, J., & Kuna, P. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.06.023 · Cited by 16
Neuroendocrine–Immune Interactions: Implications for Health and Behavior
Pace, T. W. W., Raison, C. L., & Miller, A. H. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00083-8 · Cited by 15
Self-citationTime-dependent effects of striatal interleukin-2 on open field behaviour in rats
Karrenbauer, B. D., Ho, Y., Ludwig, V., Löhn, J., Spanagel, R., Schwarting, R. K. W., & Pawlak, C. R. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.003 · Cited by 14
“Finally, first evidence showed that cytokines increase self-reported fatigue, which was correlated to increased glucose metabolism in the nucleus accumbens and putamen (Capuron et al., 2007).”
BackgroundBekhbat, M., Block, A. M., Dickinson, S. Y., Tharpd, G. K., Bosinger, S. E., & Felger, J. C. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.01.010 · Cited by 14
Regional neuronal activity in patients with relapsing remitting multiple sclerosis
Baumgärtner, A., Frings, L., Schiller, F., Stich, O., Mix, M. D., Egger, K. E., Schluh, G., Rauer, S., & Meyer, P. T. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.13012 · Cited by 13
Lowe, X. R., Marchetti, F., Lu, X., & Wyrobek, A. J. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2008.12.012 · Cited by 15
“IFN- an anti-viral cytokine (Licinio et al., 1998) is currently used for the treatment of certain viral illnesses, cancers, chronic hepatitis C and other conditions (Wichers et al., 2005; Capuron et al., 2007).”
BackgroundInfluentialBeyond Inflammation: Why Understanding the Brain Matters in Inflammatory Arthritis
Kelleher, E. M., Meouchi, R., & Irani, A. (2025) · Arthritis Care & Research · doi:10.1002/acr.25694 · Cited by 14
Cytokines as Neuromodulators: Insights From Experimental Studies With Humans and Nonhuman Primates
Martins, D., & Harrison, N. A. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.06.037 · Cited by 24
Nogo, D., Wilkialis, L., Lui, L. M. W., Nasri, F., Rosenblat, J. D., & McIntyre, R. S. (2021) · Annals of Clinical Psychiatry · doi:10.12788/acp.0034 · Cited by 10
Schroyen, G., Schramm, G., Weehaeghe, D. V., Leenaerts, N., Casteele, T. V., Blommaert, J., Koole, M. J. B., Smeets, A., Laere, K. V., Sunaert, S. G., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1021615 · Cited by 13
Psychiatric Clearance for Patients Started on Interferon-Alpha-Based Therapies
Lotrich, F. E. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12121572 · Cited by 13
La inflamación y sus desencantos: papel de las citocinas en la fisiopatología de la depresión mayor
Miller, A. H., Maletic, V., & Raison, C. L. (2010) · Psiquiatría Biológica · doi:10.1016/j.psiq.2010.04.001 · Cited by 20
Self-citationOriolo, G., Blanco‐Hinojo, L., Navinés, R., Mariñó, Z., Martín‐Hernández, D., Cavero, M., Giménez, M. D., Caso, J. R., Capuron, L., Forns, X., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.03.008 · Cited by 14
“For example, PET studies revealed increased glucose metabolism in the putamen following IFN-alpha administration, which correlated with increased fatigue (Capuron et al., 2007; Juengling et al., 2000).”
BackgroundSelf-citationThe Link Between Paraquat and Demyelination: A Review of Current Evidence
Silva, R., Sobral, A. F., Dinis-Oliveira, R., & Barbosa, D. J. (2024) · Antioxidants · doi:10.3390/antiox13111354 · Cited by 11
“Dopamine function is particularly vulnerable to elevated levels of inflammatory cytokines [128,129].”
Lipopolysaccharide Effects on Neurotransmission: Understanding Implications for Depression
Batey, L., Baumberger, B., Khoshbouei, H., & Hashemi, P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00591 · Cited by 11
Weissman-Tsukamoto, R., Carroll, K. R., & Diamond, B. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101981 · Cited by 11
“Several studies demonstrate abnormalities on EEG and MRI in patients who have received IFN therapy [245-247].”
Fialho, R., Pereira, M., Harrison, N. A., Rusted, J. M., & Whale, R. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.03.049 · Cited by 8
“Capuron et al. (2007), in a study with patients with malignant melanoma, found that four weeks of IFN-α therapy was associated with marked increased in glucose metabolism in basal ganglia, and a significant increase in fatigue, lassitude and “inability to feel”.”
Coch, C., Viviani, R., Breitfeld, J., Münzer, K., Daßler‐Plenker, J., Holdenrieder, S., Coenen, M., Steffens, M., Müller, M., Hartmann, G., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102020 · Cited by 7
Regional brain structural alterations in reward and salience networks in asthma
Carrol, D., Busse, W. W., Frye, C. J., Klaus, D. R., Bach, J. C., Floerke, H. L., Bendlin, B. B., Zetterberg, H., Blennow, K., Heslegrave, A., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.01.028 · Cited by 6
“…a priori , based on their previous implication in inflammation-related functional alterations (dorsal and ventral striatum (Capuron et al., 2012; Capuron et al., 2007; Ritz et al., 2020; Chen et al., 2019; Eisenberger et al., 2010), pallidum (Marsland et al., 2015; Ritz et al., 2020; Chen et…”
Suchting, R., Razouq, D., Jose, L., Nascimento, F., Wardle, M. C., Soares, J. C., Teixeira, A. L., & Selvaraj, S. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.03.019 · Cited by 8
Felger, J. C. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-21054-9_16 · Cited by 6
Yennemadi, A. S., Jameson, G., Glass, M., Pasquale, C. D., Keane, J., Bianchi, M., & Leisching, G. R. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104741 · Cited by 5
Olson, K. L., Saligan, L. N., & Piper, B. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-90990-5_3 · Cited by 8
The Role of Immune System in Depression Disorder
Hoseinzadeh, F., Abadi, P. H., Agheltar, M., Aghayinejad, A., Torabian, F., Rezayat, A. A., Akbarzadeh, F., & Rahimi, H. R. (2016) · Health · doi:10.4236/health.2016.815167 · Cited by 6
Piper, B. F., Olson, K. L., & Hagelin, C. L. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1225-1_3 · Cited by 6
Understanding cancer-related fatigue: advancing the science
Renner, M. A., & Saligan, L. N. (2016) · Fatigue Biomedicine Health & Behavior · doi:10.1080/21641846.2016.1246513 · Cited by 6
Periche-Tomas, E., Cattaneo, A., Cattane, N., Bone, C., Tibble, J. A., Bullmore, E. T., Pariante, C. M., & Harrison, N. A. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.038 · Cited by 5
“…1998) and IFN-induced fatigue/ motivational impairment has been associated with disruption of basal ganglia glucose metabolism, dopamine turnover (Capuron et al., 2007; Nakagawa et al., 2016), glutamate/glutamine concentrations (Haroon et al., 2014) and tissue microstructure (Harrison et al.,…”
The Inflammatory Hypothesis of Depression
Soskin, D. P., Cassiello-Robbins, C. F., Isacoff, O. K., & Fava, M. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.4.413 · Cited by 5
Microcystis aeruginosa decreased fish appetite via inducing intestinal inflammation
Ju, Z., Xiang, Q., Xia, T., Harshaw, K., Rooney, N., Zi, J., Hong, Z., & Chang, X. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110428 · Cited by 6
Developing interferon-β as a safe in vivo experimental-medicine model of human inflammation
Periche-Tomas, E., Underwood, J., MacIver, C., Leach, H., Bone, C., Guy, C., Triantafilou, K., Szomolay, B., Jones, S. A., & Harrison, N. A. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106173 · Cited by 4
The Application of PET Imaging in Psychoneuroimmunology Research
Hannestad, J. O. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-071-7_17 · Cited by 4
Fialho, R., Pereira, M., Gilleece, Y. C., Rusted, J. M., & Whale, R. (2018) · Women & Health · doi:10.1080/03630242.2018.1449778 · Cited by 5
Inflammation, Sickness Behaviour and Depression
Khandaker, G. M., Colasanti, A., & Harrison, N. A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.008 · Cited by 5
Rus, T., Mlakar, J., Jamšek, J., & Trošt, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713081 · Cited by 4
“, isolated cases of autoimmune encephalitis, especially anti-LGI1 encephalitis [22,23], exposure to cocaine, amphetamines [21], interferon-α treatment [24], and some uncommon movement disorders of various etiology).”
BackgroundHengenius, J. B., Ehrenkranz, R. C., Zhu, X., Glynn, N. W., Huppert, T. J., & Rosano, C. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112388 · Cited by 6
“In cancer patients, higher cross-sectional SEL was associated with higher glucose metabolism in portions of the left striatum (Capuron et al., 2007).”
Panek, M., Karbownik, M. S., & Kuna, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241750 · Cited by 4
Biology of Depression and Cytokines in Cancer
Musselman, D. L., Miller, A. H., Royster, E. B., & McNutt, M. D. (2010) · Wiley eBooks · doi:10.1002/9780470972533.ch3 · Cited by 6
Self-citationNeurochemical drivers of effort: The roles of dopamine and beyond in physical and cognitive exertion
Periche-Tomas, E., Husain, M., Apps, M. A. J., Little, S. J., & Harmer, C. J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106696 · Cited by 4
“…of depressive episodes in one-third of the treated patients (Capuron et al., 2002; Udina et al., 2012), with higher occurrence of symptoms such as lack of energy, fatigue or psychomotor retardation (Capuron et al., 2007; Dowell et al., 2016, 2019; Felger et al., 2012; Felger and Treadway, 2017).”
Los efectos conductuales modulados por las citocinas
Becerril‐Villanueva, E., Gutiérrez, M. E. H., Granados-Camacho, I., Alvarez, L., Pérez‐Tapia, S. M., & Romero, L. P. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 5
Barlow, S., Fahey, B., Smith, K. J., Passecker, J., Della-Chiesa, A., Hok, V., Day, J. S., Callaghan, C. K., & O’Mara, S. M. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.012 · Cited by 3
Metadata
- Authors
- Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H.
- Affiliations
- Emory University (US)
- Corresponding author
- Miller, Andrew H
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-28
- Volume
- 32
- Issue
- 11
- Pages
- 2384-2392
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2072184805
- Cited by
- 229
- References
- 70
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 9 · 2020: 15 · 2019: 10 · 2018: 17 · 2017: 12 · 2016: 18 · 2015: 17 · 2014: 8 · 2013: 14 · 2012: 22
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Funders
- Abbott Laboratories
- American Foundation for Suicide Prevention
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- American Psychiatric Institute for Research and Education
- Emory University
- National Alliance for Research on Schizophrenia and Depression
- ACADIA Pharmaceuticals
- Neurocrine Biosciences
- Centers for Disease Control and Prevention
- Pfizer Pharmaceuticals
- National Institute of Mental Health (MH 067990, R01MH067990, MH069124, K05MH069124)
- National Institute on Drug Abuse (K08DA000367, DA-00367)
- National Institute of Biomedical Imaging and Bioengineering (EB002635, R01EB002635)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- interferon-alpha, basal ganglia, fatigue, glucose metabolism, nucleus accumbens, putamen, cerebellum, prefrontal cortex, melanoma, lassitude, immune-related adverse events
- MeSH terms
- Adult, Basal Ganglia, Behavioral Symptoms, Brain Mapping, Female, Humans, Immunologic Factors, Longitudinal Studies, Male, Middle Aged, Fatigue Syndrome, Chronic, Interferon-alpha, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.